Skip to main content
. Author manuscript; available in PMC: 2014 Jul 8.
Published in final edited form as: J Cyst Fibros. 2010 Nov 12;10(1):54–61. doi: 10.1016/j.jcf.2010.10.003

Figure 2.

Figure 2

Overall efficacy: A) relative change in FEV1 % predicted from baseline over three cycles (Efficacy population); B) change from baseline in Pseudomonas aeruginosa sputum density (Efficacy population).